Kalkine has a fully transformed NEW Avatar.

Select Reports


AbbVie Inc.

Company Overview: AbbVie Inc. (NYSE: ABBV) is focused on treating acute chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology; virology; neurological disorders; pain associated with endometriosis; as well as other serious health conditions. AbbVie came into existence on 1 January 2013, post the divestment of Abbott Laboratories’ pharmaceutical division. The company has a strong presence in rheumatoid arthritis, cancer, psoriasis, HIV, hepatitis C virus (HCV), Crohn’s disease, thyroid disease, Parkinson’s disease, endometriosis, ulcerative colitis, and cystic fibrosis markets. The company operates in one business segment called pharmaceutical products.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and
Terms and Conditions
Allow cookies Decline